Materias dentro de su búsqueda.
Mostrando 1,021 - 1,040 Resultados de 4,357 Para Buscar '"health economics"', tiempo de consulta: 0.41s Limitar resultados
  1. 1021
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier
  2. 1022
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study
  3. 1023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exposure-based treatments for childhood abuse-related post-traumatic stress disorder in adults: a health-economic evaluation
  4. 1024
    “…BACKGROUND: Health economic models aim to provide decision makers with information that is contextually relevant, understandable and credible. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa
  5. 1025
    “…CONCLUSIONS: In this novel review we argue that health economics may have come full circle from its roots in broad public policy economics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues
  6. 1026
    “…This study was conducted to address this gap and the growing need for naturalistic studies comparing health economics outcomes in adult patients with OAB syndrome initiating treatment with different antimuscarinic drugs in a primary care setting in Spain. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain
  7. 1027
    “…This article aims to review the published literature on point-of-care testing around the world, with a focus on health economics and the feasibility of its implementation in Australian rural and remote regions.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Review of Health Economics of Point-of-Care Testing Worldwide and Its Efficacy of Implementation in the Primary Health Care Setting in Remote Australia
  8. 1028
    “…Despite considerable steps in medical education, the teaching of management, health economics and research skills for medical doctors are often neglected in medical curricula. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    We know but we hope: A qualitative study of the opinions and experiences on the inclusion of management, health economics and research in the medical curriculum
  9. 1029
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health Economics; Retrospective (FFS) versus Prospective (DRG, Global,..) Reimbursement Systems and COVID-19 in the Health Sectors of Iran and the World
  10. 1030
    “…The clinical and health economic impacts of index HF diagnosis made on admission to hospital versus community settings are not known. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Survival and health economic outcomes in heart failure diagnosed at hospital admission versus community settings: a propensity-matched analysis
  11. 1031
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of employment support integrated in substance use treatment: A health economic cost-effectiveness simulation of three different interventions
  12. 1032
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction to: The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
  13. 1033
    “…OBJECTIVE: Comparing differences in benefits between anti-CD20 mAbs from a health-economic and societal perspective. METHODS: To reflect lifetime use of DMTs, we used a treatment-sequence model to compare ocrelizumab/ofatumumab and eight other drug classes in terms of health (lifetime relapses, time to Expanded Disability Status Scale [EDSS] 6, lifetime quality-adjusted life years) and cost-effectiveness (net health benefit). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model
  14. 1034
    “…Little is known about the adverse health, economic, and social impacts of substandard and falsified medicines (SFMs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health, Economic, and Social Impacts of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review of Methodological Approaches
  15. 1035
    “…We developed a prognostic model that could be used to inform risk-stratified decisions on frequency of monitoring blood-tests during long-term thiopurine treatment, and, performed health-economic evaluation of alternate monitoring intervals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation
  16. 1036
    por Schlander, Michael
    Publicado 2007
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence
  17. 1037
    “…RESULTS: Among 5910 retrieved publications, 25 medical articles, as well as seven health economic studies meet the inclusion criteria. The medical studies show a superior weight loss following bariatric surgery compared to conventional therapy. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Evaluation of medical and health economic effectiveness of bariatric surgery (obesity surgery) versus conservative strategies in adult patients with morbid obesity
  18. 1038
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Use of information on disease diagnoses from databases for animal health economic, welfare and food safety purposes: strengths and limitations of recordings
  19. 1039
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK
  20. 1040
    “…This analysis includes the epidemiology of low-risk HPV types allowing for the comparison between the two vaccines (HPV-16/18 AS04-adjuvanted vaccine and the HPV-6/11/16/18 vaccine), latest cross-protection data on HPV vaccines, treatment costs for cervical cancer, vaccine costs and 6% discounting per the health economic guideline for Chile. RESULTS: Projected incremental cost-utility ratio (ICUR) and incremental cost-effectiveness ratio (ICERs) for the HPV-16/18 AS04-adjuvanted vaccine was 116 United States (US) dollars per quality-adjusted life years (QALY) gained or 147 US dollars per life-years (LY) saved, while the projected ICUR/ICER for the HPV-6/11/16/18 vaccine was 541 US dollars per QALY gained or 726 US dollars per LY saved. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model
Herramientas de búsqueda: RSS